NBIX

Neurocrine Biosciences
D

NBIX

137.880
USD
-1.06
(-0.76%)
مغلق
حجم التداول
27,107
الربح لكل سهم
7
العائد الربحي
-
P/E
33
حجم السوق
13,747,421,640
أصول ذات صلة المقالات

العنوان: Neurocrine Biosciences

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.